Welcome to our dedicated page for Intuitive Surgical news (Ticker: ISRG), a resource for investors and traders seeking the latest updates and insights on Intuitive Surgical stock.
Intuitive Surgical, Inc. (ISRG) is a medical technology company headquartered in Sunnyvale, California and known for its role in minimally invasive care and robotic-assisted surgery. Its news flow frequently centers on developments related to the da Vinci surgical systems and the Ion endoluminal system, along with financial performance updates and regulatory milestones.
Investors and healthcare professionals following ISRG news can expect regular earnings announcements, where the company reports quarterly and preliminary annual financial results. These updates typically highlight worldwide procedure growth on da Vinci and Ion platforms, changes in the installed base of systems, and trends in systems, instruments, and accessories revenue.
Another major category of Intuitive news involves product clearances and platform enhancements. Recent press releases describe FDA clearances expanding indications for the da Vinci Single Port (SP) system to additional general surgery procedures, clearance of advanced energy instruments such as Vessel Sealer Curved, and regulatory certifications for the da Vinci 5 system in regions including the European Union and Japan. News also covers software and digital features for da Vinci 5, such as Force Gauge, In-Console Video Replay, and Network CCM for remote software updates.
Intuitive’s news feed also includes updates on the Ion endoluminal system, including FDA-cleared software releases that introduce artificial intelligence across Ion’s navigational workflow and integrate advanced imaging capabilities to support lung biopsy procedures. Additional stories describe demonstrations of telesurgery capabilities using da Vinci 5 and collaborations with hospitals adopting newer platforms.
For those tracking ISRG, this news page provides a consolidated view of company press releases, allowing readers to monitor procedure and system trends, regulatory progress, and technology updates that shape Intuitive’s position in robotic-assisted surgery and minimally invasive care.
Intuitive Surgical (Nasdaq: ISRG) has launched Intuitive Ventures, a $100 million fund aimed at investing in minimally invasive care innovations. This fund will focus on early-stage companies in digital tools, precision diagnostics, and therapeutic technologies. Julian Nikolchev, President of Intuitive Ventures, emphasizes the goal to enhance the continuum of care. With a leadership team experienced in healthcare investment, Intuitive Ventures aims to leverage industry expertise to drive positive healthcare outcomes.
Intuitive (Nasdaq: ISRG) reported Q3 financial results for 2020, revealing a revenue decline of 4% year-over-year to $1,078 million. The company shipped 195 da Vinci Surgical Systems, a decrease of 29% compared to 2019. Despite challenges from COVID-19, da Vinci procedures increased by 7%, and the installed base grew to 5,865 systems, up 8% from last year. Net income fell to $314 million, or $2.60 per diluted share, down from $397 million, or $3.33 per diluted share in Q3 2019. The company also launched a $100 million fund for healthcare innovations.
Intuitive (Nasdaq: ISRG) reported Q2 2020 revenue of $852 million, down 22% from $1,099 million in Q2 2019, heavily impacted by the COVID-19 pandemic. Worldwide da Vinci procedures declined 19%, and the shipment of da Vinci Surgical Systems fell 35% to 178 units. The installed base of systems grew 9% to 5,764. GAAP net income was $68 million ($0.57/share), down from $318 million ($2.67/share) last year. The company ended the quarter with $6.1 billion in cash and equivalents. Despite challenges, Intuitive launched an 'Extended Use Program' for instruments to improve economic efficacy.
Summary not available.
Summary not available.